Escamilla-Gómez, Virginia https://orcid.org/0000-0002-0639-574X
García Gutiérrez, Valentín https://orcid.org/0000-0003-4752-0815
Alcalde-Mellado, Patricia
Astibia-Mahillo, Beatriz https://orcid.org/0000-0002-9387-0288
Chinea-Rodriguez, Anabelle
López-Corral, Lucía
Acera-Gómez, Marina
Torres Ochando, Melissa Karina
Borrero Borrego, Asunción
González Pinedo, Leslie
Zudaire Ripa, Teresa
González Vicent, Marta https://orcid.org/0000-0002-4845-5616
Benzaquén, Ana https://orcid.org/0000-0003-4015-0831
Izquierdo Garcia, Isabel https://orcid.org/0000-0002-3599-4901
Asensi Cantó, Pedro https://orcid.org/0000-0002-6504-3656
Montoro, Juan https://orcid.org/0000-0003-0024-8068
Martín-Domínguez, Francisco Manuel
Orti, Guillermo https://orcid.org/0000-0002-7889-5807
Valcárcel, David
Benitez-Carabante, Maria Isabel https://orcid.org/0000-0002-5366-8384
Diaz-de-Heredia, Cristina
Cañamero, Eloi
Ferrá, Christelle
García-Cadenas, Irene https://orcid.org/0000-0002-2994-9055
Redondo, Sara https://orcid.org/0000-0001-8967-7410
Sisinni, Luisa
Perez-Martínez, Antonio https://orcid.org/0000-0002-6436-9195
Mussetti, Alberto
Garcia-Mañó, Lucía
Palomo-Moraleda, María Del Pilar
González-Sierra, Pedro Antonio https://orcid.org/0000-0002-6492-1728
Jurado, Manuel
Perez-Simon, Jose A. https://orcid.org/0000-0003-3616-6101
,
Vallejos, Ana Benzaquén
Garcia, Isabel Izquierdo
Cantó, Pedro Asensi
Domínguez, Francisco Manuel Martín
Carabante, Maria Isabel Benítez
Giro, Eloi Cañamero
Martínez, Antonio Perez
Maño, Lucía García
Chacón, Manuel Jurado
Funding for this research was provided by:
Novartis Farmacéutica
Article History
Received: 16 June 2024
Revised: 13 November 2024
Accepted: 19 November 2024
First Online: 11 December 2024
Competing interests
: The study was funded by Novartis Company. VGG and GETH-TC received support from Novartis Company. The rest of the authors declare no competing financial interests.